BMRN fund manager activity
BioMarin Pharmaceutical Inc · Nasdaq. Reported by 9 tracked fund managers in their 13F filings, Q1 2014 to Q2 2026.
Q2 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Added | 15,108,310 | $830,503,801 | 0.47% | Aug 13, 2025 |
| Paul Singer - Elliott Investment Management | Sold out | — | — | 0.00% | Nov 14, 2025 |
| Ken Fisher - Fisher Asset Management | Trimmed | 13,545 | $744,581 | 0.00% | Aug 13, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 119,446 | $6,565,947 | 0.04% | Aug 14, 2025 |
| Viking Global Investors | Added | 12,288,611 | $675,504,947 | 1.95% | Aug 14, 2025 |
Q1 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Added | 14,955,240 | $1,057,185,916 | 0.60% | May 14, 2025 |
| Paul Singer - Elliott Investment Management | No change | 3,500,338 | $247,438,893 | 2.27% | May 15, 2025 |
| Ken Fisher - Fisher Asset Management | Trimmed | 13,573 | $959,538 | 0.00% | May 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 47,469 | $3,355,584 | 0.03% | May 15, 2025 |
| Viking Global Investors | Added | 10,800,059 | $763,456,171 | 2.43% | May 15, 2025 |
Newer quarters · Older quarters